CHANGE IN PREFRONTAL-LIMBIC MORPHOLOGY AND COGNITION IN DRUG-NAIVE FIRST-EPISODE PSYCHOSIS PATIENTS FOLLOWING ATYPICAL ANTIPSYCHOTIC TREATMENT: A BRIEF LONGITUDINAL STUDY

被引:0
|
作者
Woodward, Melissa [1 ]
Smith, Geoffrey [1 ]
Honer, William [1 ]
Goghari, Vina [2 ]
Kopala, Lili [1 ]
Gicas, Kristina [1 ]
Thornton, Allen [3 ]
Su, Wayne [1 ]
MacEwan, William [1 ]
Lang, Donna [1 ]
机构
[1] Univ British Columbia, Vancouver, BC, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Simon Fraser Univ, Burnaby, BC, Canada
关键词
D O I
10.1093/schbul/sby017.712
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
F181
引用
收藏
页码:S291 / S292
页数:2
相关论文
共 50 条
  • [31] Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-tenn treatment with either a typical or an atypical antipsychotic drug
    Glenthoj, Andreas
    Glenthoj, Birte Y.
    Mackeprang, Torben
    Pagsberg, Anne K.
    Hemmingsen, Ralf P.
    Jernigan, Terry L.
    Baare, William F. C.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2007, 154 (03) : 199 - 208
  • [32] Inflammatory Activity and Brain Volumes in Drug-Naive Patients with First-Episode Psychosis: A State-Dependent Study
    Serpa, Mauricio H.
    Doshi, Jimit
    Viera, Erica L. M.
    Chaim, Tiffany M.
    van de Bilt, Martinus T.
    Sallet, Paulo
    Gattaz, Wagner F.
    Teixeira, Antonio L.
    Busatto, Geraldo F.
    Davatzikos, Christos
    Zanetti, Marcus V.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 361S - 361S
  • [33] Longitudinal Effects of Antipsychotic Treatment on Functional Connectivity of the Striatum in Patients with First-episode Psychosis
    Sarpal, Deepak
    Robinson, Delbert G.
    Lencz, Todd
    Ikuta, Toshikazu
    Argyelan, Miklos
    Karlsgodt, Katherine H.
    Gallego, Juan A.
    Kane, John
    Szeszko, Philip R.
    Malhotra, Anil
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S172 - S173
  • [34] NEUROCOGNITIVE FUNCTIONING IN DRUG-NAIVE PATIENTS WITH FIRST EPISODE OF PSYCHOSIS BEFORE AND AFTER TREATMENT
    Zaytseva, Yuliya
    Gurovich, Isaac
    Sarkisyan, Gayane
    Sarkisyan, Vagan
    PSYCHIATRIA DANUBINA, 2011, 23 : S155 - S157
  • [35] Middle temporal corpus callosum impairment as a predictor of eight-week treatment outcome of drug-naive first-episode psychosis patients: A pilot longitudinal study
    Wang, Danni
    Zhuo, Kaiming
    Sun, Yu
    Xiang, Qiong
    Guo, Xiaoyun
    Wang, Jinhong
    Xu, Yifeng
    Liu, Dengtang
    Li, Yao
    SCHIZOPHRENIA RESEARCH, 2021, 232 : 95 - 97
  • [36] N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naive Schizophrenia Patients
    Zong, Xiaofen
    Hu, Maolin
    Li, Zongchang
    Cao, Hongbao
    He, Ying
    Liao, Yanhui
    Zhou, Jun
    Sang, Deen
    Zhao, Hongzeng
    Tang, Jinsong
    Lv, Luxian
    Chen, Xiaogang
    SCIENTIFIC REPORTS, 2015, 5
  • [37] SENSORIMOTOR GATING IN FIRST-EPISODE, ANTIPSYCHOTIC-NAIVE SCHIZOPHRENIA PATIENTS: A LONGITUDINAL STUDY
    Aggernaes, Bodil
    Oranje, B.
    Glenthoj, B.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 46 - 47
  • [38] Comparison of baseline metabolic variables between drug-naive first-episode psychosis patients and healthy controls
    Parrilla, M. A.
    Sengupta, S. M.
    Kin, N. M.
    Klink, R.
    Stip, E.
    Baptista, T.
    Malla, A.
    Joober, R.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 244 - 244
  • [39] Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients
    Manuel Delgado-Alvarado
    Diana Tordesillas-Gutierrez
    Rosa Ayesa-Arriola
    Manuel Canal
    Victor Ortiz-García de la Foz
    Javier Labad
    Benedicto Crespo-Facorro
    Archives of Women's Mental Health, 2019, 22 : 367 - 373
  • [40] Plasma prolactin levels are associated with the severity of illness in drug-naive first-episode psychosis female patients
    Delgado-Alvarado, Manuel
    Tordesillas-Gutierrez, Diana
    Ayesa-Arriola, Rosa
    Canal, Manuel
    Ortiz-Garcia de la Foz, Victor
    Labad, Javier
    Crespo-Facorro, Benedicto
    ARCHIVES OF WOMENS MENTAL HEALTH, 2019, 22 (03) : 367 - 373